- Home
- Publications
- Publication Search
- Publication Details
Title
New insights into IL-12-mediated tumor suppression
Authors
Keywords
-
Journal
CELL DEATH AND DIFFERENTIATION
Volume 22, Issue 2, Pages 237-246
Publisher
Springer Nature
Online
2014-09-05
DOI
10.1038/cdd.2014.134
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The immunocytokine NHS-IL12 as a potential cancer therapeutic
- (2015) Jonathan Fallon et al. Oncotarget
- A phase II trial of intraperitoneal EGEN-001, an IL-12 plasmid formulated with PEG–PEI–cholesterol lipopolymer in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer: A Gynecologic Oncology Group study
- (2014) Ronald D. Alvarez et al. GYNECOLOGIC ONCOLOGY
- Antiproliferative Activity of IL-27 on Melanoma
- (2014) T. Yoshimoto et al. JOURNAL OF IMMUNOLOGY
- IL-12 receptor 1 deficiency alters in vivo T follicular helper cell response in humans
- (2013) N. Schmitt et al. BLOOD
- Preexisting antitumor immunity augments the antitumor effects of chemotherapy
- (2013) Lingbing Zhang et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Intratumoral IL-12 combined with CTLA-4 blockade elicits T cell–mediated glioma rejection
- (2013) Johannes vom Berg et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Tumor-Derived IL-35 Promotes Tumor Growth by Enhancing Myeloid Cell Accumulation and Angiogenesis
- (2013) Z. Wang et al. JOURNAL OF IMMUNOLOGY
- Enhanced Antitumor Response Mediated by the Codelivery of Paclitaxel and Adenoviral Vector Expressing IL-12
- (2013) Linjie Cao et al. MOLECULAR PHARMACEUTICS
- Collapse of the Tumor Stroma is Triggered by IL-12 Induction of Fas
- (2013) Sid P Kerkar et al. MOLECULAR THERAPY
- IL-27 in tumor immunity and immunotherapy
- (2013) Gopal Murugaiyan et al. TRENDS IN MOLECULAR MEDICINE
- Tumor-targeted T cells modified to secrete IL-12 eradicate systemic tumors without need for prior conditioning
- (2012) H. J. Pegram et al. BLOOD
- Combination of vinblastine and oncolytic herpes simplex virus vector expressing IL-12 therapy increases antitumor and antiangiogenic effects in prostate cancer models
- (2012) B J Passer et al. CANCER GENE THERAPY
- Intratumoral electroporation of IL-12 cDNA eradicates established melanomas by Trp2180–188-specific CD8+ CTLs in a perforin/granzyme-mediated and IFN-γ-dependent manner: application of Trp2180–188 peptides
- (2012) Jeong-Im Sin et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Interleukin-27 Inhibits the Growth of Pediatric Acute Myeloid Leukemia in NOD/SCID/Il2rg-/- Mice
- (2012) A. Zorzoli et al. CLINICAL CANCER RESEARCH
- IL-12 family cytokines: immunological playmakers
- (2012) Dario A A Vignali et al. NATURE IMMUNOLOGY
- An Il12-Il2-Antibody Fusion Protein Targeting Hodgkin's Lymphoma Cells Potentiates Activation Of Nk And T Cells For An Anti-Tumor Attack
- (2012) Tobias Jahn et al. PLoS One
- IL-12 selectively programs effector pathways that are stably expressed in human CD8+ effector memory T cells in vivo
- (2011) F. Z. Chowdhury et al. BLOOD
- The antitumor effects of adenoviral-mediated, intratumoral delivery of interleukin 23 require endogenous IL-12
- (2011) J Reay et al. CANCER GENE THERAPY
- Anti-IL-23 Monoclonal Antibody Synergizes in Combination with Targeted Therapies or IL-2 to Suppress Tumor Growth and Metastases
- (2011) M. W. L. Teng et al. CANCER RESEARCH
- A Phase 1 Study of AS1409, a Novel Antibody-Cytokine Fusion Protein, in Patients with Malignant Melanoma or Renal Cell Carcinoma
- (2011) S. M. Rudman et al. CLINICAL CANCER RESEARCH
- Anti-leukemic properties of IL-12, IL-23 and IL-27: Differences and similarities in the control of pediatric B acute lymphoblastic leukemia
- (2011) Claudia Cocco et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- The effects of mesenchymal stem cells injected via different routes on modified IL-12-mediated antitumor activity
- (2011) S H Seo et al. GENE THERAPY
- IL-12 inhibits the TGF-β-dependent T cell developmental programs and skews the TGF-β-induced differentiation into a Th1-like direction
- (2011) Jana Prochazkova et al. IMMUNOBIOLOGY
- IL-12 triggers a programmatic change in dysfunctional myeloid-derived cells within mouse tumors
- (2011) Sid P. Kerkar et al. JOURNAL OF CLINICAL INVESTIGATION
- Enhanced Sensitivity to IL-2 Signaling Regulates the Clinical Responsiveness of IL-12-Primed CD8+ T Cells in a Melanoma Model
- (2011) D. N. Lisiero et al. JOURNAL OF IMMUNOLOGY
- IL-12 Enhances the Antitumor Actions of Trastuzumab via NK Cell IFN- Production
- (2011) A. C. Jaime-Ramirez et al. JOURNAL OF IMMUNOLOGY
- Reversal of gastrointestinal carcinoma-induced immunosuppression and induction of antitumoural immunity by a combination of cyclophosphamide and gene transfer of IL-12
- (2011) Mariana Malvicini et al. Molecular Oncology
- Improving Adoptive T Cell Therapy by Targeting and Controlling IL-12 Expression to the Tumor Environment
- (2011) Ling Zhang et al. MOLECULAR THERAPY
- Cytokines in Cancer Immunotherapy
- (2011) Sylvia Lee et al. Cancers
- Interleukin-27 Acts as Multifunctional Antitumor Agent in Multiple Myeloma
- (2010) C. Cocco et al. CLINICAL CANCER RESEARCH
- IL-12 Suppresses Vascular Endothelial Growth Factor Receptor 3 Expression on Tumor Vessels by Two Distinct IFN-γ–Dependent Mechanisms
- (2010) Elizabeth W. Sorensen et al. JOURNAL OF IMMUNOLOGY
- IL-12 initiates tumor rejection via lymphoid tissue–inducer cells bearing the natural cytotoxicity receptor NKp46
- (2010) Maya Eisenring et al. NATURE IMMUNOLOGY
- Semliki Forest virus-mediated gene therapy of the RG2 rat glioma
- (2010) F. P. Roche et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- IL-23 suppresses innate immune response independently of IL-17A during carcinogenesis and metastasis
- (2010) M. W. L. Teng et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Expression, engineering and characterization of the tumor-targeting heterodimeric immunocytokine F8-IL12
- (2010) Roberto Sommavilla et al. PROTEIN ENGINEERING DESIGN & SELECTION
- A safety and efficacy study of local delivery of interleukin-12 transgene by PPC polymer in a model of experimental glioma
- (2009) Adam M. Sonabend et al. ANTI-CANCER DRUGS
- Intratumoral delivery of encapsulated IL-12, IL-18 and TNF-α in a model of metastatic breast cancer
- (2009) Michael S. Sabel et al. BREAST CANCER RESEARCH AND TREATMENT
- A Novel Synergistic Combination of Cyclophosphamide and Gene Transfer of Interleukin-12 Eradicates Colorectal Carcinoma in Mice
- (2009) M. Malvicini et al. CLINICAL CANCER RESEARCH
- A Novel Functional Polymorphism, 16974 A/C, in the Interleukin-12-3′ Untranslated Region Is Associated with Risk of Glioma
- (2009) Bang Zhao et al. DNA AND CELL BIOLOGY
- Phase-I clinical trial of IL-12 plasmid/lipopolymer complexes for the treatment of recurrent ovarian cancer
- (2009) K Anwer et al. GENE THERAPY
- Intracerebral Interleukin 12 Induces Glioma Rejection in the Brain Predominantly by CD8+T Cells and Independently of Interferon-γ
- (2009) Marcus Vetter et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Phase II study of interleukin-12 for treatment of plateau phase multiple myeloma (E1A96): A trial of the Eastern Cooperative Oncology Group
- (2009) Martha Q. Lacy et al. LEUKEMIA RESEARCH
- A phase I trial of paclitaxel and trastuzumab in combination with interleukin-12 in patients with HER2/neu-expressing malignancies
- (2009) T. S. Bekaii-Saab et al. MOLECULAR CANCER THERAPEUTICS
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started